SCHEMBL7316409

SCHEMBL7316409

CC(C)(CN)NCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.46
CYP3A4 P08684 4/20 0.46
CYP2D6 P10635 4/20 0.46
CYP1A2 P05177 2/20 0.46
PRMT1 Q99873 1/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TAAR1 Q96RJ0 2/20 0.43
SLC6A2 P23975 1/20 0.43
THRB P10828 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
RIPK1 Q13546 1/20 0.41
ATM Q13315 1/20 0.41
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19963515 0.83 CYP2D6 (0.48) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL11751773 0.83 CYP2D6 (0.48) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL6747065 0.82 CYP1A2 (0.43) IDO1CYP1A2MAPTKDM4ETAAR1
SCHEMBL6891746 0.81 RIPK1 (0.50) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL11818840 0.81 LMNA (0.63) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL16741453 0.80 LOXL2 (0.45) LMNALOXL2HTT
SCHEMBL29193469 0.80 NPC1 (0.50) IDO1CYP3A4CYP2D6CYP1A2PRMT1
SCHEMBL11747108 0.79 CYP2D6 (0.45) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL6098836 0.79 CYP3A4 (0.46) IDO1CYP3A4CYP2D6LMNAMAPT
SCHEMBL20163215 0.79 RIPK1 (0.49) IDO1CYP3A4CYP2D6LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106928017-B Method for preparing 1,1,1,4,4, 4-hexafluoro-2-butene 浙江省化工研究院有限公司 2020-12-08 CN claimed
CN-106925354-B Liquid phase catalyst for preparing halogenated olefin 浙江省化工研究院有限公司 2020-04-17 CN claimed
EP-0293925-A2 Compound active in cardiovascular therapy SIMES, SOCIETA ITALIANA MEDICINALI E SINTETICI, S.P.A. (IT) 1988-12-07 EP disclosed